Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-22 Purchase |
2023-05-24 5:09 pm |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
896,522 | $25.33 | $22,707,098 | 39,523,425 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 6:54 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
5,947 | $22.5 | $133,808 | 30,970 (Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 6:48 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
15,310 | $22.5 | $344,475 | 71,469 (Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 6:43 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
14,869 | $22.5 | $334,553 | 73,920 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-02 7:06 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
917 | $21.18 | $19,422 | 25,513 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-02 7:04 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
548 | $21.18 | $11,607 | 9,487 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-02 7:02 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
7,806 | $21.18 | $165,331 | 108,297 (Direct) |
View |
| 2023-04-10 Sale |
2023-04-11 9:15 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
523 | $18.14 | $9,487 | 6,686 (Direct) |
View |
| 2023-04-06 Sale |
2023-04-07 8:44 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
1,751 | $18.16 | $31,798 | 23,540 (Direct) |
View |
| 2023-04-06 Sale |
2023-04-07 8:41 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
701 | $18.16 | $12,730 | 10,261 (Direct) |
View |
| 2023-04-06 Sale |
2023-04-07 8:37 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
1,916 | $18.16 | $34,795 | 23,303 (Direct) |
View |
| 2023-04-06 Sale |
2023-04-07 8:34 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
8,582 | $18.16 | $155,849 | 152,478 (Direct) |
View |
| 2023-04-06 Sale |
2023-04-07 8:32 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
1,456 | $18.16 | $26,441 | 37,744 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 9:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
350 | $18.78 | $6,573 | 4,603 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 9:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
577 | $18.78 | $10,836 | 6,824 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 9:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
3,851 | $18.78 | $72,322 | 113,619 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 9:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
803 | $18.78 | $15,080 | 24,536 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-27 9:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
461 | $18.78 | $8,658 | 7,409 (Direct) |
View |
| 2023-01-12 Sale |
2023-01-17 5:17 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
12,500 | $18.25 | $228,125 | 0 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-10 8:38 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
3,904 | $17.13 | $66,877 | 94,161 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-10 8:30 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
532 | $17.13 | $9,113 | 8,409 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-10 8:20 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
589 | $17.13 | $10,090 | 20,331 (Direct) |
View |
| 2022-11-21 Sale |
2022-11-22 4:34 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
1,847 | $15.07 | $27,834 | 61,234 (Direct) |
View |
| 2022-10-15 Sale |
2022-10-18 9:22 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
1,326 | $15.81 | $20,964 | 56,831 (Direct) |
View |
| 2022-10-15 Sale |
2022-10-18 9:16 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
2,804 | $15.81 | $44,331 | 79,009 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-01 Option Award |
2023-06-05 9:43 pm |
N/A 2033-06-01 |
ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director |
17,697 | $0 | 17,697 (Direct) |
View |
| 2021-06-22 Exercise |
2023-06-05 9:42 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
18,002 | $0 | 35,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:42 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
17,697 | $0 | 35,699 (Direct) |
View |
| 2021-06-22 Exercise |
2023-06-05 9:39 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director |
18,002 | $0 | 36,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:39 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director |
17,697 | $0 | 36,699 (Direct) |
View |
| 2021-06-22 Exercise |
2023-06-05 9:38 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director |
18,002 | $0 | 35,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:38 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director |
17,697 | $0 | 35,699 (Direct) |
View |
| 2022-06-07 Exercise |
2023-06-05 9:34 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
16,862 | $0 | 36,477 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:34 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
17,697 | $0 | 36,477 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:14 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
35,394 | $0 | 39,558,819 (Indirect) |
View |
| 2023-05-23 Exercise |
2023-05-24 5:09 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
12,500 | $17.01 | 39,523,425 (Indirect) |
View |
| 2023-05-23 Exercise |
2023-05-24 5:09 pm |
N/A 2023-06-07 |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
25,000 | $0 | 39,523,425 (Indirect) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:54 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
11,894 | $0 | 30,970 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:48 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
29,738 | $0 | 71,469 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:43 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
29,738 | $0 | 73,920 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 9:17 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
117,195 | $0 | 117,195 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 9:16 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
385,067 | $0 | 385,067 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 9:15 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
117,195 | $0 | 117,195 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 9:14 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
78,129 | $0 | 78,129 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 9:13 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
27,515 | $0 | 27,515 (Direct) |
View |
| 2023-04-29 Exercise |
2023-05-02 7:06 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
3,005 | $0 | 25,513 (Direct) |
View |
| 2023-04-29 Exercise |
2023-05-02 7:04 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
1,567 | $0 | 9,487 (Direct) |
View |
| 2023-04-29 Exercise |
2023-05-02 7:02 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
15,625 | $0 | 108,297 (Direct) |
View |
| 2023-04-07 Exercise |
2023-04-11 9:15 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
1,489 | $0 | 6,686 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 8:44 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
5,024 | $0 | 23,540 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 8:41 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
2,009 | $0 | 10,261 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 8:37 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
5,275 | $0 | 23,303 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 8:34 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
17,333 | $0 | 152,478 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 8:32 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
4,773 | $0 | 37,744 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 9:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
840 | $0 | 4,603 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 9:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
1,353 | $0 | 6,824 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 9:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
10,945 | $0 | 113,619 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 9:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
2,214 | $0 | 24,536 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 9:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
1,107 | $0 | 7,409 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-13 6:45 pm |
N/A 2033-02-09 |
ACADIA PHARMACEUTICALS INC | ACAD | Williamson Douglas J Executive VP, Research & Dev |
287,951 | $0 | 287,951 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-17 5:17 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
12,500 | $17.01 | 0 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-17 5:17 pm |
N/A 2023-06-06 |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
12,500 | $0 | 0 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-17 4:22 pm |
N/A 2023-01-17 |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
30,000 | $0 | 38,690,733 (Indirect) |
View |
| 2023-01-12 Exercise |
2023-01-17 4:22 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
15,000 | $5.22 | 38,690,733 (Indirect) |
View |
| 2023-01-06 Exercise |
2023-01-10 8:38 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
9,528 | $0 | 94,161 (Direct) |
View |
| 2022-01-06 Exercise |
2023-01-10 8:30 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
2,572 | $0 | 8,409 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-10 8:20 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
1,633 | $0 | 20,331 (Direct) |
View |
| 2022-11-21 Exercise |
2022-11-22 4:34 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
12,500 | $0 | 61,234 (Direct) |
View |
| 2022-10-15 Exercise |
2022-10-18 9:22 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
2,969 | $0 | 56,831 (Direct) |
View |
| 2022-10-15 Exercise |
2022-10-18 9:16 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
5,938 | $0 | 79,009 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-14 7:09 pm |
N/A 2032-10-11 |
ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director |
22,839 | $0 | 22,839 (Direct) |
View |